Commonwealth Equity Services
CLSD

Commonwealth Equity Services’s Clearside Biomedical CLSD Stock Holding History

Commonwealth Equity Services’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,500
Closed -$18K – 4269
2025
Q2 		$18K Hold
1,500
– – ﹤0.01% 4220
2025
Q1 		$21K Buy
1,500
+833
+125% +$12K ﹤0.01% 4121
2024
Q4 		$10K Hold
667
– – ﹤0.01% 4068
2024
Q3 		$13K Hold
667
– – ﹤0.01% 4023
2024
Q2 		$13K Buy
+667
New +$12.9K ﹤0.01% 3987

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Commonwealth Equity Services's CLSD Position: Q3 2025 in Review

Commonwealth Equity Services sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 1,500 shares — an estimated $18K sold.

Commonwealth Equity Services first reported a position in CLSD in Q2 2024 and held it in 5 quarters. The position peaked at $21K in Q1 2025. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Commonwealth Equity Services reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,500 Clearside Biomedical shares in Q3 2025, an estimated $18K.
  • Commonwealth Equity Services first reported a position in Clearside Biomedical in Q2 2024 and held it in 5 quarters.
  • Commonwealth Equity Services's Clearside Biomedical position peaked at $21K in Q1 2025.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.